Tilray | TRLY - Trade Debtors



Tilray reported $112.74M in Trade Debtors for its fiscal quarter ending in November of 2024.


Trade Debtors Change Date
Acasti Pharma USD 20K 281K Jun/2025
Alaunos Therapeutics USD 5K 5K Dec/2024
Aurora Cannabis CAD 39.14M 10.38M Jun/2025
Avita Medical AUD 11.96M 1.95M Dec/2024
Canopy Growth CAD 50.03M 972K Jun/2025
Cronos Group USD 53.14M 21.39M Jun/2025
Dianthus Therapeutics USD 39K 768K Jun/2025
Divis Laboratories Ltd 27.44B 5.42B Mar/2025
Ionis Pharmaceuticals USD 52.58M 12.87M Jun/2025
IQVIA Holdings USD 3.41B 95M Jun/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Moderna USD 457M 151M Jun/2025
Organigram Holdings CAD 57.55M 10.46M Jun/2025
Organon & Co USD 1.48B 27M Jun/2025
Revvity USD 661.14M 43.72M Jun/2025
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 112.74M 8.7M Nov/2024
Viatris USD 3.6B 208.8M Jun/2025
Xeris Pharmaceuticals USD 53.05M 12.64M Jun/2025